Reliance Capital sells stakes to Nippon, exits mutual funds business
By Akshay Kedari  Date: 2019-05-25

Reliance Capital sells stakes to Nippon, exits mutual funds business

Reliance Capital, a financial services company has recently entered an agreement with Nippon Life Insurance of Japan, for exiting its stake in Reliance Nippon Life Asset Management, reports source.

For the record, Nippon Life Insurance made initial investment in RNAM, in 2012. The company is 130-years old and is one of the largest Life Insurance companies in Japan. It manages assets of $700 billion, revenues of over $70 billion & core operating profit of approximately $6.8 billion.

The company employs 70,000 employees & serves around 14 million customers, worldwide. It has been investing globally in asset management companies and have acquired 24.75 % stake in TCW of U.S. at the end of 2017 & 5% stake in DWS of Germany in March last year. It runs operations internationally- across Asia, Europe, U.S. & Australian region.

As per industry experts, the current share of the partners in the JV is 42.88%, the rest of the share is with public shareholders. According to the agreement, Nippon Life is expected to make an open offer of RNAM at Rs 230 per share to the public shareholders under SEBI regulations and reach maximum permissible promoter shareholding of 75% for listed companies, indicating Nippon to hold 75% stake in the asset management company.

Anil Dhirubhai Ambani, Chairman of Reliance Group was reportedly quoted saying that the monetization of RNAM stake is a part of company’s value unlocking strategy. The transaction is expected to reduce RCAP’s debt by 50 % in the current fiscal year, he added.  JM Financial Ltd. acted as an advisor for the transaction.

As specified in the SEBI Takeover Regulations, the transaction amount represents a premium of 15.5% to the minimum 60-day price. Reliance Capital is expected to receive approximately Rs 6,000 crore by selling off its shareholding to Nippon Life Insurance at Rs 230 per share & simultaneously OFS (Offer for Sale) to other financial investors. The proposed transaction is expected to reduce 33% of Reliance Capital’s debt. The transaction is subject to regulatory approvals, cites source.

Source credits: https://www.moneycontrol.com/news/business/companies/reliance-capital-to-sell-entire-stake-in-amc-jv-to-nippon-life-4010421.html

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
CStone Pharmaceuticals, Pfizer finalize a $200 million share sale deal
By Akshay Kedari

Chinese biotechnology company, CStone Pharmaceuticals has recently announced that it has completed the Share Subscription Agreement with Pfizer Inc. for its newly issued shares worth US$200 million. The move furthers the biotech’s multifaceted ...

Researchers bag $6Mn grant to study the link between Parkinson’s & aging
Researchers bag $6Mn grant to study the link between Parkinson’s & aging
By Akshay Kedari

A three-year grant worth $6 million, funded by the Michael J. Fox Foundation, was recently awarded to a collaborative research team from Michigan’s Van Andel Institute (VAI) and the University of Minnesota Medical School. The grant was given th...

EY announces availability of OpsChain Network Procurement solution
EY announces availability of OpsChain Network Procurement solution
By Akshay Kedari

Ernst & Young (EY), a global professional services network, has recently announced the availability of a first-of-its-kind OpsChain Network Procurement solution. The solution has been built on the company’s OpsChain platform. It will enabl...

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...